A Widely Used Class of Weight-Loss Drugs Just Got a Fresh Caution From Regulators

The FDA said on November 9, 2026 that GLP-1 drugs, including Ozempic and Wegovy, must carry an updated warning about a rare eye condition linked to sudden vision loss. For home cooks and grocery shoppers, the change matters because these medicines can affect how people plan meals, manage diabetes, and talk with their care team about side effects. Continue Reading →